ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

Vanderbilt Lung Cancer Trial For Never Smokers Online

September 25, 2009

In Brief: Lee Helman To Head NCI Pediatric Branch; HHS to Hear From Academic Health Centers

August 22, 1997

Obit: Shirley Lansky, 66, Illinois Cancer Center Director, Dead.

November 30, 2001

In Brief: NCI Names Rice To Head Frederick Center; NIAID Appoints Killen DAIDS Director

April 22, 1994